Assignee
CELLTRION INC
KR·30 granted patents·17 pending applications·22 citations·filing 2009–2024
Top patents by PatentIndex Score
47 records- 0191US10980881B2Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycineCELLTRION INC·Filed 2018·Granted Apr 20, 2021·7 cites·20 claims
- 0285US11986523B2Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycineCELLTRION INC·Filed 2021·Granted May 21, 2024·1 cites·14 claims
- 0379US9834594B2Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A virusesCELLTRION INC·Filed 2017·Granted Dec 5, 2017·2 cites·23 claims
- 0478US9856312B2Binding molecule having influenza A virus-neutralizing activity produced from human B cellCELLTRION INC·Filed 2016·Granted Jan 2, 2018·3 cites·13 claims
- 0577US9814784B2Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing sameCELLTRION INC·Filed 2014·Granted Nov 14, 2017·2 cites·24 claims
- 0677US2024358827A1Stable liquid formulaCELLTRION INC·Filed 2024·Application pending·0 cites
- 0775US9278996B2Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the sameCELLTRION INC·Filed 2013·Granted Mar 8, 2016·2 cites·14 claims
- 0875US2024269069A1Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2024·Application pending·0 cites
- 0975US2024269071A1Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2024·Application pending·0 cites
- 1072US12188036B2Expression cassette for production of high-expression and high-functionality target protein and use thereofCELLTRION INC·Filed 2018·Granted Jan 7, 2025·1 cites·8 claims
- 1170US9475861B2Binding molecule having influenza A virus-neutralizing activity produced from human B cellCELLTRION INC·Filed 2012·Granted Oct 25, 2016·2 cites·16 claims
- 1270US2025002573A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2024·Application pending·0 cites
- 1370US2025084433A1Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use ThereofCELLTRION INC·Filed 2024·Application pending·0 cites
- 1469US10703802B2Composition comprising at least two influenza A virus-neutralizing-binding moleculesCELLTRION INC·Filed 2014·Granted Jul 7, 2020·1 cites·25 claims
- 1568US10722571B2Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically theretoCELLTRION INC·Filed 2016·Granted Jul 28, 2020·1 cites·15 claims
- 1664US11951207B2Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2017·Granted Apr 9, 2024·0 cites·14 claims
- 1759US12534738B2Expression cassette including intron for high expression of protein of interest and use thereofCELLTRION INC·Filed 2020·Granted Jan 27, 2026·0 cites·13 claims
- 1858US12419863B2Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathyCELLTRION INC·Filed 2019·Granted Sep 23, 2025·0 cites·11 claims
- 1958US11730698B2Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2019·Granted Aug 22, 2023·0 cites·25 claims
- 2058US2025266155A1Clinical Supplies Management Method And Device Using SameCELLTRION INC·Filed 2021·Application pending·0 cites
- 2156US11236146B2Stable pharmaceutical formulationCELLTRION INC·Filed 2017·Granted Feb 1, 2022·0 cites·13 claims
- 2254US11202751B2Whitening cosmetic composition comprising Caragana sinica root extractCELLTRION INC·Filed 2016·Granted Dec 21, 2021·0 cites·2 claims
- 2354US10947497B2Nelumbo nucifera callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing sameCELLTRION INC·Filed 2017·Granted Mar 16, 2021·0 cites·5 claims
- 2454US10610587B2Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing sameCELLTRION INC·Filed 2018·Granted Apr 7, 2020·0 cites·4 claims
- 2554US2020390842A1Composition for alleviating skin inflammation caused by yellow dust and fine particulate, comprising natural plant extractCELLTRION INC·Filed 2020·Application pending·0 cites
- 2654US2021371510A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2018·Application pending·0 cites
- 2752US12533343B2Method for preparing (−)-cibenzoline succinateCELLTRION INC·Filed 2019·Granted Jan 27, 2026·0 cites·11 claims
- 2852US2023312683A1Stable pharmaceutical preparationCELLTRION INC·Filed 2021·Application pending·0 cites
- 2950US12551465B2Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same compositionCELLTRION INC·Filed 2021·Granted Feb 17, 2026·0 cites·14 claims
- 3049US12546779B2Binding molecule having neutralizing activity against SARS-coronavirus-2CELLTRION INC·Filed 2021·Granted Feb 10, 2026·0 cites·10 claims
- 3149US2025263468A1Binding molecule having neutralizing activity against coronavirus superfamilyCELLTRION INC·Filed 2021·Application pending·0 cites
- 3249US2023110839A1Varicella zoster virus fusion protein and immunogenic composition comprising sameCELLTRION INC·Filed 2021·Application pending·0 cites
- 3349US2022153828A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2020·Application pending·0 cites
- 3448US10239902B2Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising sameCELLTRION INC·Filed 2017·Granted Mar 26, 2019·0 cites·9 claims
- 3548US2018207222A1Composition for alleviating skin inflammation caused by yellow dust and fine particulate, comprising natural plant extractCELLTRION INC·Filed 2016·Application pending·0 cites
- 3648US2024066110A1Immunogenic Composition Comprising Multivalent Streptococcus Pneumoniae Polysaccharide-Protein ConjugatesCELLTRION INC·Filed 2022·Application pending·0 cites
- 3745US12157764B2Dosing regimen for treating influenza virus diseasesCELLTRION INC·Filed 2019·Granted Dec 3, 2024·0 cites·10 claims
- 3844US2023040902A1Pharmaceutical Formulation Comprising Cibenzoline or Salt ThereofCELLTRION INC·Filed 2020·Application pending·0 cites
- 3943US11007136B2Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllumCELLTRION INC·Filed 2016·Granted May 18, 2021·0 cites·3 claims
- 4043US8361790B2Human host cell for producing recombinant proteins with high quality and quantityCELLTRION INC·Filed 2009·Granted Jan 29, 2013·0 cites·5 claims
- 4143US2018008702A1Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing sameCELLTRION INC·Filed 2015·Application pending·0 cites
- 4242US12065482B2Stable liquid pharmaceutical formulation of anti-influenza virus antibodyCELLTRION INC·Filed 2017·Granted Aug 20, 2024·0 cites·9 claims
- 4342US2022177552A1Binding Molecule Having Neutralizing Activity Against Middle East Respiratory Syndrome-CoronavirusCELLTRION INC·Filed 2018·Application pending·0 cites
- 4440US10351592B2Method for separating antibody isoforms using cation exchange chromatographyCELLTRION INC·Filed 2014·Granted Jul 16, 2019·0 cites·6 claims
- 4533US12486237B2Polymorphic form of (-)-cibenzoline succinateCELLTRION INC·Filed 2021·Granted Dec 2, 2025·0 cites·14 claims
- 4633US10507240B2Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virusCELLTRION INC·Filed 2015·Granted Dec 17, 2019·0 cites·3 claims
- 4730US11712407B2Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing sameCELLTRION INC·Filed 2015·Granted Aug 1, 2023·0 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →